United States (US) Monoclonal Antibody Market (2025-2031) | Competitive Landscape, Growth, Outlook, Industry, Value, Forecast, Share, Size & Revenue, Companies, Segmentation, Trends, Analysis

Market Forecast By Source (Murine, Chimeric, Humanized, Human), By Production (In Vivo, In Vitro), By Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Others), By End use (Hospitals, Research Institutes, Others) And Competitive Landscape
Product Code: ETC9970804 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Monoclonal Antibody Market Outlook
  • Market Size of United States (US) Monoclonal Antibody Market, 2024
  • Forecast of United States (US) Monoclonal Antibody Market, 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Revenues & Volume for the Period 2021- 2031
  • United States (US) Monoclonal Antibody Market Trend Evolution
  • United States (US) Monoclonal Antibody Market Drivers and Challenges
  • United States (US) Monoclonal Antibody Price Trends
  • United States (US) Monoclonal Antibody Porter's Five Forces
  • United States (US) Monoclonal Antibody Industry Life Cycle
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Source for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Murine for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Chimeric for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Humanized for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Human for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Production for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By In Vivo for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By In Vitro for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Autoimmune Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Inflammatory Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Microbial Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By End use for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Research Institutes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Monoclonal Antibody Import Export Trade Statistics
  • Market Opportunity Assessment By Source
  • Market Opportunity Assessment By Production
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By End use
  • United States (US) Monoclonal Antibody Top Companies Market Share
  • United States (US) Monoclonal Antibody Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Monoclonal Antibody Company Profiles
  • United States (US) Monoclonal Antibody Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Monoclonal Antibody Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Monoclonal Antibody Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Monoclonal Antibody Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Monoclonal Antibody Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Monoclonal Antibody Market - Industry Life Cycle

3.4 United States (US) Monoclonal Antibody Market - Porter's Five Forces

3.5 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By Source, 2021 & 2031F

3.6 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By Production, 2021 & 2031F

3.7 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.8 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By End use, 2021 & 2031F

4 United States (US) Monoclonal Antibody Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring monoclonal antibody treatments

4.2.2 Technological advancements in monoclonal antibody research and development

4.2.3 Rising demand for targeted therapies with fewer side effects

4.3 Market Restraints

4.3.1 High cost associated with monoclonal antibody therapies

4.3.2 Stringent regulatory requirements for approval and commercialization

4.3.3 Competition from biosimilars impacting pricing and market share

5 United States (US) Monoclonal Antibody Market Trends

6 United States (US) Monoclonal Antibody Market, By Types

6.1 United States (US) Monoclonal Antibody Market, By Source

6.1.1 Overview and Analysis

6.1.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By Source, 2021- 2031F

6.1.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By Murine, 2021- 2031F

6.1.4 United States (US) Monoclonal Antibody Market Revenues & Volume, By Chimeric, 2021- 2031F

6.1.5 United States (US) Monoclonal Antibody Market Revenues & Volume, By Humanized, 2021- 2031F

6.1.6 United States (US) Monoclonal Antibody Market Revenues & Volume, By Human, 2021- 2031F

6.2 United States (US) Monoclonal Antibody Market, By Production

6.2.1 Overview and Analysis

6.2.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By In Vivo, 2021- 2031F

6.2.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By In Vitro, 2021- 2031F

6.3 United States (US) Monoclonal Antibody Market, By Indication

6.3.1 Overview and Analysis

6.3.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By Cancer, 2021- 2031F

6.3.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F

6.3.4 United States (US) Monoclonal Antibody Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F

6.3.5 United States (US) Monoclonal Antibody Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.6 United States (US) Monoclonal Antibody Market Revenues & Volume, By Microbial Diseases, 2021- 2031F

6.3.7 United States (US) Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Monoclonal Antibody Market, By End use

6.4.1 Overview and Analysis

6.4.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By Research Institutes, 2021- 2031F

6.4.4 United States (US) Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Monoclonal Antibody Market Import-Export Trade Statistics

7.1 United States (US) Monoclonal Antibody Market Export to Major Countries

7.2 United States (US) Monoclonal Antibody Market Imports from Major Countries

8 United States (US) Monoclonal Antibody Market Key Performance Indicators

8.1 Number of FDA approvals for new monoclonal antibody therapies

8.2 Research and development investment in monoclonal antibody technologies

8.3 Patient adherence and persistence rates for monoclonal antibody treatments

9 United States (US) Monoclonal Antibody Market - Opportunity Assessment

9.1 United States (US) Monoclonal Antibody Market Opportunity Assessment, By Source, 2021 & 2031F

9.2 United States (US) Monoclonal Antibody Market Opportunity Assessment, By Production, 2021 & 2031F

9.3 United States (US) Monoclonal Antibody Market Opportunity Assessment, By Indication, 2021 & 2031F

9.4 United States (US) Monoclonal Antibody Market Opportunity Assessment, By End use, 2021 & 2031F

10 United States (US) Monoclonal Antibody Market - Competitive Landscape

10.1 United States (US) Monoclonal Antibody Market Revenue Share, By Companies, 2024

10.2 United States (US) Monoclonal Antibody Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All